Description
TRODELVY® (sacituzumab govitecan-hziy) is a prescription medicine used to treat adults with triple-negative breast cancer (negative for estrogen and progesterone hormone receptors and HER2) that has spread to other parts of the body (metastatic) or cannot be removed by surgery, and who have received two or more prior treatments, including at least one treatment for metastatic disease.
Additional information
| Brand | TRODELVY® |
|---|---|
| Generic name | Sacituzumab govitecan-hziy for Injection |
| Form | Parenteral |
| Strength | 180mg |
| Manufacturer | Gilead |
| Documents | Either PO or prescription |
| Storage | 2-8°C temperature |
Reviews
There are no reviews yet.